MY ACCOUNT | NEWSLETTER |

Expression of sex hormone receptors in canine osteosarcoma


Sex steroids regulate bone metabolism directly and indirectly through receptors on bone. Estrogen receptors (ER-∝, ER-β), progesterone receptor (PR) and androgen receptor (AR), have been previously identified on human osteosarcoma (OSA) cells. These receptors influence tumor growth, but their expression and role in canine OSA is unknown.   

The aim of this study was to characterize sex hormone receptor expression levels in naturally occurring OSA tissue and in three canine OSA cell lines.   The expression of ER-α, ER-β, PR, and AR was investigated using RT-PCR. PR expression levels were also quantified in OSA cells cultured under hypoxic conditions or in the presence of estradiol. The effects of progesterone on cell proliferation were quantified.   

Results demonstrated varying expression levels of these receptors in five OSA subtypes. OSA cell lines demonstrated high gene expression levels of PR and low gene expression levels of ER-α and ER-β, and no gene expression of AR.   PR expression was increased in OSA cells cultured under hypoxic conditions in a HIF-∝ independent manner.

Interestingly, the authors noted one cell line expressed very high levels of PR, expression of which decreased in response to estradiol. In addition, progesterone decreased OSA cell proliferation in this particular cell line.   The authors concluded that further investigation of the role of sex steroids, particularly PR and its ligands, in regulation of canine OSA is recommended.

Kristyn N Dilley, et al. “Expression of Sex Hormone Receptors in Canine Osteosarcoma.” Vet Sci. 2022 Sep 25;9(10):524. doi: 10.3390/vetsci9100524.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

WVAC 2024 - April 16-19, Cape Town

Like1
Dislike0

Interview With Dr. Anthony Pease

Like0
Dislike0

Human exposures to Brucella canis from a pregnant dog during an international flight: Public health risks, diagnostic challenges, and future considerations

Like0
Dislike0

Efficacy of antimicrobial and nutraceutical treatment for canine acute diarrhoea

Like0
Dislike0

Evaluation of the clinical efficacy of racecadotril in the treatment of neonatal calves with infectious diarrhea.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top